BSECompany Update21 Oct 2026 · 21 Oct 2026, 03:04 pm

Intimation of Earnings Conference Call on Unaudited Financial Results for Quarter and Half year ended 30th September 2026

Indoco Remedies Ltd · 532612

✦ AI SummaryResults

Indoco Remedies Ltd has announced an earnings conference call for Q2 FY2026-2027, scheduled for October 27, 2026, to discuss unaudited financial results for the quarter and half year ended September 30, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Indoco Remedies Ltd - 532612 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Attachments (1)

📄

3bb1a04e-51ac-4b69-a671-4c40d3b80e78.pdf

pdf

Download →
View document text
21st October, 2026 To To The Listing Department The Listing Department National Stock Exchange of India Limited Bombay Stock Exchange Limited Exchange Plaza, Floor 25, P. J. Towers, Bandra – Kurla Complex Dalal Street, Bandra (East) Mumbai – 400 001 Mumbai – 400 051 Stock Code : 532612 Stock Code : INDOCO Dear Sir/Madam, Sub : Intimation of Earnings Conference Call on Unaudited Financial Results for Quarter and Half year ended 30th September, 2026 Pursuant to Regulation 30 read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that an Earnings Conference Call on Unaudited Financial Results for the Quarter and Half year ended 30th September, 2026 is scheduled to be held on Tuesday, 27th October, 2026 at 03:00 P.M. IST. The details of the conference call are enclosed herewith. This is for your information and dissemination on respective websites. Thanking you, Yours faithfully, For Indoco Remedies Limited Ramanathan Hariharan Company Secretary & Head Legal You are cordially invited to the Q2 FY2026-2027 Earnings Conference Call of Indoco Remedies Limited Tuesday, October 27, 2026 at 3:00PM IST Represented by: Ms. Aditi Panandikar Managing Director Mr. Sundeep V. Bambolkar Jt. Managing Director Mr. Pramod Ghorpade CFO Pre-register to avoid the waiting queue, join with DiamondPass link: Registration Link Conference Dial-In Number +91 22 6280 1116 Universal Access +91 22 7115 8017 Hong Kong: 800 964 448 Singapore: 800 101 2045 International Toll Free USA: 1 866 746 2133 UK: 0 808 101 1573 For further information, please contact: Rashmi Shetty Candice Pereira Zain Gulam Hussain Director - Research AVP Research Associate Dolat Capital Market Pvt. Ltd. Dolat Capital Market Pvt. Ltd. Dolat Capital Market Pvt. Ltd. (D) +91 22 40969724 (D) +91 22 61764873 (D) +91 22 40969790 (M) +91 22 8879111413 (M) +91 22 9833458572 (M) +91 22 9892724209 Email: rashmis@dolatcapital.com Email: candicep@dolatcapital.com Email: zain@dolatcapital.com